$SYBT

Keefe, Bruyette & Woods Raises Stock Yards Bancorp (NASDAQ:SYBT) Price Target to $80.00

Keefe, Bruyette & Woods has raised its price target for Stock Yards Bancorp (NASDAQ:SYBT) from $79.00 to $80.00, maintaining a "market perform" rating. This new target suggests a potential upside of 12.08% from the current stock price. Analyst consensus on SYBT is generally a "Hold" with an average price target of $77.75, although some firms like Hovde Group have recently upgraded the stock to "Outperform."

Original reporting
MarketBeat · MarketBeat
Published Apr 9, 2026, 7:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Apr 9, 2026, 8:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Keefe, Bruyette & Woods Raises Stock Yards Bancorp (NASDAQ:SYBT) Price Target to $80.00 — source image
Decision brief

The 30-second read

$SYBTBullishLow
01

Why it matters

The analyst upgrade may lead to short-term price appreciation, but the overall impact remains limited due to the 'market perform' rating and modest target increase.

02

Market read

The news has limited market relevance, primarily affecting short-term sentiment among regional bank investors.

03

What to watch

Potential macroeconomic headwinds or sector-specific risks could offset the positive analyst sentiment, which are not addressed in the news.

Relevance 6/10Timing: short-term

Background

Stock Yards Bancorp is a regional bank with a focus on community banking services. Recent earnings reports and sector trends influence analyst outlooks.

Company-level read

Ticker impact

$SYBTBullishMedium confidence
Context

The news pertains directly to Stock Yards Bancorp, which is represented by the ticker SYBT.

Expected impact

Potential short-term price increase of approximately 1.25% following the target raise, with a possible total upside of around 4-5% if the stock reaches the new target.

Evidence & confidence

The price target increase and upgrade suggest positive analyst sentiment, but the unchanged 'market perform' rating indicates limited strong conviction. The relevance score of 1.0 and the analyst consensus support a modest bullish bias.

Market effects

The banking sector may experience slight positive sentiment due to upward analyst revisions for regional banks.

Limited regional impact, primarily affecting investors in the bank's local markets.

Minimal global relevance; the news is specific to a regional bank.

Counterpoint

The unchanged 'market perform' rating suggests that some analysts may view the target increase as a minor adjustment rather than a significant positive signal, indicating caution.

Key entities

  • Stock Yards Bancorp

    A regional bank offering banking and financial services.

  • Keefe, Bruyette & Woods

    A financial services firm providing equity research and investment banking.

  • Hovde Group

    An investment firm that recently upgraded SYBT to 'Outperform'.

Related articles

$SYBTMed

Stock Yards Bancorp Reports Record Second Quarter Earnings of $40.1 Million or $1.31 Per Diluted Share

Stock Yards Bancorp, Inc. (SYBT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Stock Yards Bancorp Reports Record Second Quarter Earnings of $40.1 Million or $1.31 Per Diluted Share Second Quarter Highlighted by the Completed Acquisition of Field & Main Bancorp Along with Margin Expansion and Record Non-Interest Income LOUISVILLE, Ky., July 29,

$TWSTMed

Jefferies initiates Twist Bioscience stock at Hold on valuation

Jefferies initiated coverage on Twist Bioscience (TWST) with a Hold rating and $150 price target, citing premium valuation. The stock trades at $155.65 after a 391% YTD surge. Jefferies notes its market differentiation and AI-driven growth, but warns of high valuation expectations. TWST partners with Eli Lilly's TuneLab for AI/ML drug discovery, while BWS Financial rates it Sell, and Guggenheim reiterates Buy.

$RCLHigh

Jefferies upgrades Royal Caribbean stock rating on improved revenue outlook

Jefferies upgraded Royal Caribbean (RCL) to Buy with a $330 price target, citing improved occupancy and revenue per passenger. RCL trades at $282.32, with a P/E ratio of 17.66. Jefferies raised revenue estimates for Q3 2026 and FY 2027, projecting net yield growth and higher EBITDA. Despite lower EPS estimates, the firm increased valuation multiples. Other analysts also upgraded RCL, citing strategic developments and positive yield outlooks.